Medication Exposure in Older Patients With Constitutional Hemorrhagic Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

142 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-07-22

Study Completion Date

2021-01-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The improvements observed in the care of patients with hemophilia or Willebrand disease have led to an increase in their life expectancy, which today approaches that of the general population. This increase in life expectancy leads in these patients to the development of comorbidities related to aging (cardiovascular and neurological diseases, cancers and kidney diseases) (e.g "Franchini \& Mannuccio", BJH, 2009). The care of these comorbidities represents a new challenge for the medical teams. Toward multiple comorbidities, polypharmacy is often associated.

Many studies about medication exposure and management in older patients were published but no study was conducted to explore the medication management of older patients with hemophilia or Willebrand disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage

NCT06322953

Traumatic Intracranial Haemorrhage

RECRUITING PHASE3

In-hospital Falls and Hemorrhagic Complications : a Descriptive Analysis in Rennes University Hospital

NCT03687541

In-hospital Falls

COMPLETED

Occupational Integration of Adults With Severe Haemophilia in France: a Study Based on the FranceCoag Cohort

NCT03301376

Severe Haemophilia

COMPLETED

The Lived Experience of People With Von Willebrand Disease

NCT06064643

Von Willebrand Diseases

COMPLETED

Noninferiority Oral Tranexamic Acid vs Intravenous Administration in Total Hip Arthroplasty

NCT04691362

Hemorrhage Postoperative Total Blood Loss Arthroplasty Complications

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemophilia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Telephone interview

Primary objective: potentially inappropriate medication prevalence

Secondary objective:

Number and type of medication Polypharmacy prevalence Medication regimen complexity using Medication Regimen Complexity Index Anticholinergic and sedative exposure using Drug Burden Index

A telephone interview will be conducted with patients in order to collect medication data from medical prescriptions.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Community-dwelling patients over 65 years with hemophilia (A or B)
* Community-dwelling patients over 65 years with Willebrand disease (Type1, 2 and 3, rate \<30%)